Publications by authors named "M Boules"

Background: Relapse after corticosteroid withdrawal in eosinophilic esophagitis is not well understood.

Objectives: Budesonide oral suspension (BOS) 2.0 mg twice daily (b.

View Article and Find Full Text PDF

Background: Prucalopride (1 or 2 mg once daily) is approved for treating adults with chronic idiopathic constipation (CIC).

Objectives: We determined the effect of age, body mass index (BMI), and renal function on the efficacy and safety of prucalopride in adults with CIC.

Design: Data were pooled from six 12-week, phase III-IV clinical studies in adults who received prucalopride (1 or 2 mg once daily) or placebo for CIC.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how previous esophageal dilation affects the effectiveness of swallowed corticosteroids in patients with eosinophilic esophagitis (EoE), particularly focusing on the responses to treatment.
  • A post hoc analysis of a phase 3 study on budesonide oral suspension revealed that while histological responses were similar among patients regardless of dilation history, those with a history of dilation had lower dysphagia symptom response rates.
  • The findings suggest that a history of esophageal dilation might complicate the relationship between histological results and dysphagia symptom or endoscopic efficacy outcomes in EoE treatment.
View Article and Find Full Text PDF

Background And Aims: Eosinophilic esophagitis (EoE) is associated with impaired health-related quality of life (HRQoL) and stigma perceptions. Therefore, we examined the real-world impact of EoE on the daily life and ability to function in adolescents (caregiver-reported) and adults with EoE in the United States of America in a noninterventional, cross-sectional, web-based survey.

Methods: HRQoL was assessed using the Short Form Health Survey (domains: vitality and social functioning) and the European Health Interview Survey (domain: sleep).

View Article and Find Full Text PDF

This meta-analysis was designed to compare the risk of postoperative wound complications in various orthopedic surgeries (OSs) affected by the perioperative use of biologic disease-modifying anti-rheumatic drugs (bDMARDs). The odds ratio (OR) and mean difference (MD), with 95% confidence intervals (CIs), were calculated using dichotomous or continuous random or fixed-effect models, based on the meta-analysis data. This study incorporated 14 investigations conducted between 2005 and 2023, encompassing a total population of 19,021 individuals undergoing diverse OSs.

View Article and Find Full Text PDF